BeLive – Cancer Genoma Profiling Qorus Innovation in Insurance Awards 2019 - Winner

In Italy, 177.301 causes of death are related to tumor which is an overall 29% of 600.000 deceased. Tumors are the second cause of death following cardiovascular disease. Statistics evidence that there are 250 types of Cancer, 350 genes contribute to the development of Cancer and approximately there are 100.000 mutations already identified some types of lung cancer, meaning one (1) unique cancer profile. Based on these figures we decided to create an innovative insurance product for customers that have been diagnosed with advanced and non-advance, recurring and/or metastatic tumors, that have exhausted all options available through standard therapies. A complete offer that will allows customers to access personalized cancer care based on genomic profiling, which permits to identify target treatments based on individual genoma, alongside with a comprehensive assistance package called “BeLive”. “Belive” contains the following services and coverages: II° Opinion Genie, Travel 4 Treatment, Home Care Assistance, Teleconsultation, Medical Emergency Assistance and Funeral Assistance. We are the First Insurance Player on the market to offer genomic profiling for targeted cancer therapy for advanced or spread disease which is unknown or not easily accessible to clients, allowing to reduce costs tied to incorrect therapy treatments and avoiding patients with unnecessary treatments/severe side effects. Main departments currently involved are the Health BU and product/marketing teams. The products is still in the prototype phase.